The purpose of the present analysis is to calculate and compare the costs and results of the implication of the inactivated vaccine against hepatitis A virus (HAV) in the Bulgarian healthcare setting in the period of 2002-2012. A combined pharmacoeconomic and epidemiological study was performed on the basis of the prevalence of hepatitis A infection in this 10-year period. The investments in th...

BACKGROUND Prior diagnosis of Alzheimer's disease (AD) among patients later diagnosed with vascular dementia (VaD) has been associated with excess costs, suggesting potential benefits of earlier rule-out of AD diagnosis. OBJECTIVE To investigate whether prior diagnosis with AD among patients with VaD is associated with excess costs in the UK. METHODS Patients with a final VaD diagnosis, con...

Despite high expectations for the value of e-business in healthcare, its adoption remains poorly understood and under-researched. The adoption and effective utilization of e-business in the healthcare industry can potentially lead to many benefits, such as: an increased accessibility to healthcare providers, improved work-flow efficiency, a higher quality of healthcare services, decreased sched...

OBJECTIVE To present a hypothetical model of the change in economic costs and health benefits to society that result from nosocomial infection control programs. DESIGN We use a modeling framework to represent how 2 types of costs change with nosocomial infection control programs: costs incurred by the hospital sector and community health services, as well as the private costs to patients. We ...

1 Nations around the globe have shown encouraging progress that demonstrates how the effective use of ICT in healthcare can improve access to and quality of care, reduce costs, and improve satisfaction among both patients and providers. INTRODUCTION Information and communications technology (ICT) has transformed nearly every aspect of modern life, from banking to travel to commerce. The healthc...